| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5955479 | Chest | 2013 | 9 Pages |
Abstract
Despite an improvement in clinical status, unlike in PAH, mortality in SSc has not improved since the introduction of epoprostenol.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Melvyn MD, Mark D. MD, MPH, Sangeetha MS, James R. MD, Elena MD, Vallerie V. MD, FCCP,